Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies

Conditions

• Small-cell Lung Cancer

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Study Details

This study will evaluate if a direct-to-patient, de-centralized, remote approach will improve clinical research outreach and engagement for patients with SCLC, in the context of a bio-specimen collection study. The study will also assess self-reported preferences and needs of patients with SCLC, regarding choosing and accessing novel therapies in research or standard clinical care settings and supportive gaps in this area, through an initial and 3 month follow up survey.

Key Dates

Start date

May 23, 2025

Status verified

Jul 2025

Primary completion

Dec 31, 2026

Completion

Jun 30, 2027

Study Design

Enrollment

30 participants (estimated)

Arms

• Arm: SCLC (primary de novo)
  Blood collection, survey (baseline and Month 3)
• Arm: SCLC (transformed)
  Blood collection, survey (baseline and Month 3)

Primary Outcome Measure

Feasibility of conducting trial in SCLC population [ Time Frame: 12 months ]

Central Contacts

• Allison Harper, PharmD
  833-333-7252
  [email protected]

Locations (52)

Find similar trials in Multiple Locations, AL

Related Studies

• Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer
  Recruiting · Emory University · Atlanta, Georgia
• A Multicenter Cancer Biospecimen Collection Study
  Recruiting · Cofactor Genomics, Inc. · San Francisco, California
• Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)
  PHASE2 · Recruiting · University of Chicago · Chicago, Illinois
• A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
  PHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey